AK Kakkar

Prevention and treatment of venous thromboembolism - International Consensus Statement (Guidelines according to scientific evidence)

Nicolaides An, Jawed Fareed, AK Kakkar et al. · UCL Discovery (University College London) · 2006 · 389 citations

Pulmonary Embolism, Thrombosis, International Consensus Statement +9

PERIOPERATIVE HEPARIN-THERAPY INHIBITS LATE DEATH FROM METASTATIC CANCER

AK Kakkar, R. Hedges, R C N Williamson et al. · International Journal of Oncology · 1995 · 38 citations

Surgical Oncology, Year Mortality, Surgery +16

A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE).

M.N. Levine, Ay Lee, Ross Baker et al. · UCL Discovery (University College London) · 2002 · 14 citations

Thrombosis, Venous Thrombosis, Medicine +10

Oral SNAC-heparin vs. enoxaparin for preventing venous thromboembolism following total hip replacement

RD Hull, AK Kakkar, V. J. Marder et al. · Journal of Thrombosis and Haemostasis · 2003 · 12 citations

Thrombosis, Venous Thrombosis, Total Hip Replacement +6

Treatment of acute, symptomatic, proximal deep vein thrombosis with the oral, direct Factor Xa inhibitor rivaroxaban (BAY 59-7939) - the ODIXa-DVT dose-ranging study

Giancarlo Agnelli, Alexander Gallus, Samuel Z. Goldhaber et al. · 2006 · 11 citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +9